Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Tuberculosis

  Free Subscription


17.09.2018

1 Clin Infect Dis
2 Eur Respir J
1 Infect Immun
1 J Clin Microbiol
1 J Infect Dis
3 Lancet
1 PLoS Med
6 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Infect Dis

  1. FOX GJ, Nguyen VN, Dinh NS, Nghiem LPH, et al
    Post-treatment Mortality Among Patients With Tuberculosis: A Prospective Cohort Study of 10 964 Patients in Vietnam.
    Clin Infect Dis. 2018 Sep 7. pii: 5092716. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur Respir J

  2. MIGLIORI GB, Sotgiu G, Rosales-Klintz S, van der Werf MJ, et al
    European Union standard for tuberculosis care on treatment of multidrug-resistant tuberculosis following publication of the new World Health Organization recommendations.
    Eur Respir J. 2018 Sep 12. pii: 13993003.01617-2018.
    PubMed     Text format    

  3. CABIBBE AM, Walker TM, Niemann S, Cirillo DM, et al
    Whole Genome Sequencing of Mycobacterium tuberculosis.
    Eur Respir J. 2018 Sep 12. pii: 13993003.01163-2018.
    PubMed     Text format     Abstract available


    Infect Immun

  4. KAUFFMAN KD, Sallin MA, Hoft SG, Sakai S, et al
    Limited pulmonary mucosal-associated invariant T cell accumulation and activation during Mycobacterium tuberculosis infection in rhesus macaques.
    Infect Immun. 2018 Sep 10. pii: IAI.00431-18. doi: 10.1128/IAI.00431.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  5. WYLLIE DH, Robinson E, Peto T, Crook DW, et al
    Identifying mixed Mycobacterium tuberculosis infection and laboratory cross-contamination during Mycobacterial sequencing programs.
    J Clin Microbiol. 2018 Sep 12. pii: JCM.00923-18. doi: 10.1128/JCM.00923.
    PubMed     Text format     Abstract available


    J Infect Dis

  6. ARUMUGAM P, Shankaran D, Bothra A, Gandotra S, et al
    The MmpS6-MmpL6 operon is an oxidative stress response system providing selective advantage to Mycobacterium tuberculosis in stress.
    J Infect Dis. 2018 Sep 7. pii: 5092676. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet

  7. REUTER A, Furin J
    Reducing harm in the treatment of multidrug-resistant tuberculosis.
    Lancet. 2018;392:797-798.
    PubMed     Text format    

  8. FARMER PE
    Better and safer treatment for multidrug-resistant tuberculosis.
    Lancet. 2018;392:798-800.
    PubMed     Text format    

  9. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    PubMed     Text format     Abstract available


    PLoS Med

  10. SUTHAR AB, Moonan PK, Alexander HL
    Towards national systems for continuous surveillance of antimicrobial resistance: Lessons from tuberculosis.
    PLoS Med. 2018;15:e1002658.
    PubMed     Text format     Abstract available


    PLoS One

  11. MOHR E, Snyman L, Mbakaz Z, Caldwell J, et al
    "Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa.
    PLoS One. 2018;13:e0203888.
    PubMed     Text format     Abstract available

  12. TOGUN TO, MacLean E, Kampmann B, Pai M, et al
    Biomarkers for diagnosis of childhood tuberculosis: A systematic review.
    PLoS One. 2018;13:e0204029.
    PubMed     Text format     Abstract available

  13. RAHMAN SMM, Maliha UT, Ahmed S, Kabir S, et al
    Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis.
    PLoS One. 2018;13:e0203063.
    PubMed     Text format     Abstract available

  14. HUAMAN MA, Henson D, Rondan PL, Ticona E, et al
    Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru.
    PLoS One. 2018;13:e0202191.
    PubMed     Text format     Abstract available

  15. BHAVANAM S, Rayat GR, Keelan M, Kunimoto D, et al
    Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.
    PLoS One. 2018;13:e0203822.
    PubMed     Text format     Abstract available

  16. MADEIRA DE OLIVEIRA S, Altmayer S, Zanon M, Alves Sidney-Filho L, et al
    Predictors of noncompliance to pulmonary tuberculosis treatment: An insight from South America.
    PLoS One. 2018;13:e0202593.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  17. GORSICH EE, Etienne RS, Medlock J, Beechler BR, et al
    Opposite outcomes of coinfection at individual and population scales.
    Proc Natl Acad Sci U S A. 2018;115:7545-7550.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: